Asthma continues to affect millions of patients, yet many still experience poor disease control and recurrent attacks. These attacks remain a major driver of hospitalizations, diminished quality of life, and long-term disease progression, placing ongoing strain on patients, families, and the healthcare system.
This session will explore the human, clinical, and system-level challenges of managing asthma, alongside evolving strategies to improve outcomes through patient-centered care. We will examine the day to day impact of asthma and frequent attacks, while examining system barriers to optimal care in the United States.
The event will be hosted by Teva Pharmaceuticals. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health.
Disclaimer:
By registering for this event, you acknowledge that if you are a healthcare professional (HCP), any transfer of value provided to you in connection with this event, including meals, travel, accommodation, or other items of value, may be subject to disclosure under applicable transparency regulations. Such disclosures may be reported to relevant authorities as required by law and may be made publicly available.
Learning Objectives
- The objective of this program is to bring awareness to the challenges of managing Asthma.
Agenda
4:30 PM - 5:15 PM | Registration and Networking |
5:15 PM - 6:45 PM | Event and Presentation |
6:45 PM - 7:30 PM | Wrap-up and Networking |
Additional Event Information
- Online registration deadline: 21 May 2026
- Event is open to: HBA Members and Non-members
-
This event is not refundable.
-
Onsite (walk -in) registration: Is Not Allowed